Ultragenyx Pharma (RARE) PT Raised to $141 at BofA Securities
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.49 +0.42%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $141.00 (from $126.00) while maintaining a Neutral rating.
- Crysvita FY20 sales in-line amid COVID
- Adding Angelman to their model
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tactical Resources completes Plum merger, set for Nasdaq debut
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
